drugset / Trial / NCT07354217
Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation
Phase 4
Not yet recruiting
60 enrolled
National Taiwan University Hospital
Johnson & Johnson · collab
RandomizedParallel-groupSingle-blindOther
Summary
To evaluate the efficacy and safety of intravenous lidocaine in reducing diaphragmatic contraction and suppressing the cough reflex during pulsed field ablation procedures.
Timeline
- Start
- 2026-06-01
- Primary completion
- 2030-12-31
- Completion
- 2030-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 1 mg/kg | Intravenous |